These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 8431499
1. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry. Morris MJ, Gilbert JD, Hsieh JY, Matuszewski BK, Ramjit HG, Bayne WF. Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499 [Abstract] [Full Text] [Related]
2. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Lilja JJ, Kivistö KT, Neuvonen PJ. Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065 [Abstract] [Full Text] [Related]
3. An automated method for the simultaneous determination of pravastatin and its main metabolite in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Kawabata K, Matsushima N, Sasahara K. Biomed Chromatogr; 1998 Aug; 12(5):271-5. PubMed ID: 9787898 [Abstract] [Full Text] [Related]
7. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. Serajuddin AT, Ranadive SA, Mahoney EM. J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703 [Abstract] [Full Text] [Related]
8. Determination of two HMG-CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography-tandem mass spectrometry for pharmaceutical study. Deng JW, Kim KB, Song IS, Shon JH, Zhou HH, Liu KH, Shin JG. Biomed Chromatogr; 2008 Feb; 22(2):131-5. PubMed ID: 17703482 [Abstract] [Full Text] [Related]
13. Microsample determination of lovastatin and its hydroxy acid metabolite in mouse and rat plasma by liquid chromatography/ionspray tandem mass spectrometry. Wu Y, Zhao J, Henion J, Korfmacher WA, Lapiguera AP, Lin CC. J Mass Spectrom; 1997 Apr; 32(4):379-87. PubMed ID: 9130396 [Abstract] [Full Text] [Related]
14. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens. Mosley ST, Kalinowski SS, Schafer BL, Tanaka RD. J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368 [Abstract] [Full Text] [Related]
18. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs. Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW. Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500 [Abstract] [Full Text] [Related]
19. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins. Escobales N, Crespo MJ, Altieri PI, Furilla RA. J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483 [Abstract] [Full Text] [Related]
20. Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry. Funke PT, Ivashkiv E, Arnold ME, Cohen AI. Biomed Environ Mass Spectrom; 1989 Oct; 18(10):904-9. PubMed ID: 2508807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]